A Phase 2 interventional study of Hippocampal stimulation using repetitive transcranial magnetic stimulation (rTMS) and Sham stimulation using repetitive transcranial magnetic stimulation (rTMS) in PTSD - Post Traumatic Stress Disorder and Intrusive Memories of Traumatic Event(s), sponsored by Tel Aviv University. Recruiting at 1 site in Israel. Open to participants aged 20 Years to 65 Years. Per ClinicalTrials.gov, last updated 2024-11-01.
Sponsored by Tel Aviv University · Phase 2, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
The goal of this clinical trial is to learn if non-invasive neurostimulation of memory-related brain areas works to treat intrusive memory symptoms in adults patients with posttraumatic stress disorder (PTSD). It will also learn about the effect of this neuromodulation procedure on reorganization of memory-related brain networks. The main questions it aims to answer are:
Does neuromodulation lower the number of times and the emotional severity participants intrusive memories? Does neuromodulation reduces the overall severity of PTSD? Researchers will compare neuromodulation targeting the hippocampus (a memory-related brain structure) to a control stimulation in an area not related to memory processes to see if hippocampus neuromodulation works to treat intrusive trauma memories and PTSD.
Participants will:
Keep a daily diary of their symptoms and the number of times they experience intrusive trauma memories.
Intrusive trauma memories are a hallmark of posttraumatic stress disorder (PTSD), and the least treatment responsive. Thus, revealing neurocognitive mechanisms associated with intrusive trauma memories has been indexed a priority. Prior work shows that targeting hippocampal circuitry modulates functional connectivity among distributed cortical-hippocampal network regions and alters memory performance in healthy participants. In the current clinical trial we test hypotheses on the clinical effects of such stimulation in a two-arms randomized controlled trial: Trauma memory reactivation + targeted hippocampal transcranial magnetic stimulation TMS (R-H-TMS) and Trauma memory reactivation + Control TMS (over the SMA; R-C-TMS). We will test a) Hippocampus seed-based connectivity patterns - revealing the impact of the targeted stimulation on extended memory brain networks; and b) frequency and severity of intrusive memory symptoms. The R-H-TMS vs. R-C-TMS contrast will speak to specificity of the noted effects to hippocampal stimulation.
204 studies on the registry are indexed under Combat Disorders; 93 are open to participants now.
This study's planned enrollment of 60 is below the median of 72 across 171 interventional studies indexed under Combat Disorders.
Browse Combat Disorders studies →Tel Aviv University is the lead sponsor of 101 studies on the registry; 27 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Inclusion Criteria:
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.
DSM diagnostic criteria
The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Brain stimulation using repetitive transcranial magnetic stimulation (rTMS) will be given after a deliberate memory re-activation, using repetitive pulses at 1Hz frequency for 15 minutes, once a week over 5 weeks. The scalp stimulation area will be determined based on a resting state fMRI scan identifying a cortical area that is most strongly functionally connected to the left hippocampal target of each patient.
Device: Hippocampal stimulation using repetitive transcranial magnetic stimulation (rTMS)
Brain stimulation using repetitive transcranial magnetic stimulation (rTMS) will be given after a deliberate memory re-activation, using repetitive pulses at 1Hz frequency for 15 minutes, once a week over 5 weeks. The scalp stimulation area will be determined based on a resting state fMRI scan identifying a cortical area that has near zero functional connectivity with the left hippocampal target of each patient.
Device: Sham stimulation using repetitive transcranial magnetic stimulation (rTMS)
We will use fMRI resting state data to personalize a TMS inhibitory stimulation to a cortical location that is the most strongly connected to a deeper left hippocampal target. 5 once a week sessions of rTMS will be delivered at 1-Hz stimulation frequency for 15 minutes following trauma memory reactivation.
Also known as: TMS, MRI
We will use fMRI resting state data to personalize a TMS sham stimulation to a cortical location with near zero connectivity to a deeper left hippocampal target. 5 once a week sessions of rTMS will be delivered at 1-Hz stimulation frequency for 15 minutes following trauma memory reactivation.
Also known as: TMS, MRI
Clinician-Administered PTSD Scale for DSM-5 (CAPS-5) Total score
The CAPS-5 is a 30-item structured interview that can be used to make current (past month or week) diagnosis of PTSD \& make lifetime diagnosis of PTSD.
Time frame: Baseline, 6 weeks, 3-months
PTSD Checklist for DSM-5 (PCL-5)
The PCL-5 is a 20-item self-reported measured based on the DSM-5 PTSD symptoms and assessing PTSD symptoms endorsement and severity.
Time frame: Baseline, 6 weeks, 3-months
Intrusive trauma memories diary
The amount, frequency and emotional effect of intrusive traumatic memories, measured by a daily self-report digital diary.
Time frame: Through study completion, an average of 8 weeks
Patient Health Questionnaire - 9 (PHQ-9)
Measures severity of depression symptoms as listed in the DSM-5
Time frame: Baseline, 6 weeks, 3-months
credibility/expectancy questionnaire (CEQ)
Measures treatment expectancies and credibility
Time frame: Baseline
fMRI Neuroimaging
Functional connectivity, indicating the level of synchronous activity of certain brain regions during rest (temporal correlation is usually expressed as a Pearson's r). Derived from the fMRI scans, and compared between the two groups as a function of time.
Time frame: Baseline, 6 weeks
Plan to share: Yes — De-identified data from the study will be shared in accordance with local laws related to patient data sharing.
Supporting information: Study protocol, Statistical analysis plan
Time frame: Uploaded by October 2026 (before data analyses starts), will stay on.
Access criteria: Deidentified clinical outcome data will be deposited in an open access repository in compliance with local patient information sharing laws. Reference to the repository will be embedded in the published report for unrestricted access. De-identified MRI data matrices will be shared upon request and in compliance with local patient information sharing laws.
No publications or documents are linked to this record.
Started Nov 2024 (actual). Primary completion is estimated for Oct 2027, 35 months after the start.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.